Assuta Ashdod University Hospi

Ashdod, Southern District 7747629

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Myelofibrosis, Severe Acute Respiratory Syndrome Coronavirus 2

Studies at this site

• A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment — Running, not enrolling
• Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19 — Completed